secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immuneering Corp (IMRX)
CIK:        0001790340
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001790340-23-000029
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immuneering re-elects two directors, ratifies auditor at annual meeting
-----------------------------------------------------------------------

- Peter Feinberg re-elected as Class II director with 18,604,285 votes for, 659,292 withheld.
- Laurie B. Keating re-elected as Class II director with 18,640,672 votes for, 622,905 withheld.
- Ratification of RSM US LLP as auditor approved: 22,595,867 for, 14,843 against, 100 abstain.
- Approximately 77.3% of outstanding shares were represented at the June 14, 2023 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1790340/000179034023000029/0001790340-23-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1790340/000179034023000029/imrx-20230614.htm
  HTML page:      https://secwatch.observer/filing/0001790340-23-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer